1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Dipeptidyl Peptidase

Dipeptidyl Peptidase (二肽基肽酶)

DPP

Dipeptidyl Peptidases are widely distributed exopeptidases that possess central role in proteolysis. The dipeptidyl peptidase family, including DPP-IV DPP7, DPP8, DPP9, fibroblast activation protein and others, cleave the peptide bond after the penultimate proline residue and are drug target rich.

DPP-IV (DPP4 or CD26) is a serine protease detected on several immune cells and on epithelial cells of various organs. Besides the membrane-bound enzyme, a catalytically active soluble form is detected in several body fluids. Both variants cleave off dipeptides from the N-termini of various chemokines, neuropeptides, and hormones. DPP IV plays a key role in immune-regulation, inflammation, oxidative stress, cell adhesion, and apoptosis by targeting different substrates. DPP IV inhibitors are commonly used as hypoglycemic agents.

DPP8 and DPP9 show DPPIV-like activity and share a very high-sequence similarity to each other. DPP8 and DPP9 are intracellular N-terminal dipeptidyl peptidases (preferentially postproline) associated with pathophysiological roles in immune response and cancer biology.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-111174A
    Diprotin A TFA Inhibitor 99.55%
    Diprotin A TFA (Ile-Pro-Ile TFA) 是二肽基肽酶 IV (DPP-IV) 的抑制剂。
    Diprotin A TFA
  • HY-14877
    Anagliptin

    利格列汀

    Inhibitor 99.91%
    Anagliptin (SK-0403) 是一种高选择性的、有效的、具有口服活性的二肽酰肽酶 4 (DPP-4) 抑制剂,IC50 值为 3.8 nM,对 DPP-8DDP-9 的选择性相对较弱,IC50 值分别为 68 nM 和 60 nM。
    Anagliptin
  • HY-14892A
    Gemigliptin tartrate

    吉格列汀酒石酸盐

    Inhibitor 98.17%
    Gemigliptin tartrate (LC15-0444 tartrate) 是一种高度选择性的,可逆的,竞争性的二肽基肽酶 4 (DPP-4) 抑制剂,对人重组 DPP-4 作用的 IC50 值为 10.3 nM。Gemigliptin tartrate 具有很强的抗糖基化特性。Gemigliptin tartrate 可用于晚期糖基化终产物 (AGE) 相关的糖尿病并发症的研究。
    Gemigliptin tartrate
  • HY-14806B
    Teneligliptin hydrobromide hydrate

    氢溴酸替格列汀水合物

    Inhibitor 99.87%
    Teneligliptin hydrobromide hydrate 是一种有效的 DPP-4 抑制剂,竞争性抑制人血浆、大鼠血浆和重组人 DPP-4 的活性,IC50 值约为 1 nM。
    Teneligliptin hydrobromide hydrate
  • HY-103433
    K579 Inhibitor ≥99.0%
    K579 是一种有效且具有口服活性的 二肽基肽酶 IV 抑制剂。K579 抑制血糖升高。K579 增加血浆胰岛素和胰高血糖素样肽-1 (GLP-1) 的活性形式。K579 具有糖尿病研究潜力。
    K579
  • HY-14806A
    Teneligliptin hydrobromide Inhibitor 99.99%
    Teneligliptin hydrobromide (MP-513 hydrobromide) 是一种抗高血压剂,为 β2 肾上腺素能受体 (β2AR) 阻滞剂,具有抗氧化、清除自由基的活性。
    Teneligliptin hydrobromide
  • HY-P4633
    γ-Glu-Tyr Inhibitor 98.19%
    γ-Glu-Tyr 是二肽基肽酶-IV (DPP-IV) 的竞争性抑制剂 (IC50=6.77 mM),是 2 型糖尿病饮食中的潜在功能成分。
    γ-Glu-Tyr
  • HY-112668
    Retagliptin phosphate

    磷酸瑞格列汀

    Inhibitor 99.89%
    Retagliptin phosphate (SP2086 phosphate) 是一种选择性的竞争性,且具有口服活性的二肽基肽酶 4 (DPP-4) 抑制剂。Retagliptin phosphate 可用于 2 型糖尿病 (T2DM) 的研究。
    Retagliptin phosphate
  • HY-15408A
    Trelagliptin succinate

    曲格列汀琥珀酸盐

    Inhibitor 99.96%
    Trelagliptin (SYR-472) succinate 是一种有效的,具有口服活性 DPP-4 抑制剂,IC50 为4 nM。Trelagliptin (SYR-472) succinate 改善体内血糖控制,可用于2 型糖尿病 (T2DM) 的研究。
    Trelagliptin succinate
  • HY-108319
    DPP-IV-IN-2 Inhibitor ≥98.0%
    DPP-IV-IN-2 是二肽基肽酶 IV (DPIV) 和 DP8/9 的抑制剂, 其 IC50 值分别为 0.1 和 0.95 μM。
    DPP-IV-IN-2
  • HY-101769
    UAMC00039 dihydrochloride Inhibitor 99.81%
    UAMC00039 dihydrochloride是高效,可逆,竞争性的dipeptidyl peptidase II抑制剂,IC50值为0.48 nM。
    UAMC00039 dihydrochloride
  • HY-13233B
    Talabostat isomer mesylate ≥98.0%
    Talabostat isomer mesylate 是 talabostat mesylate 的同分异构体。Talabostat 是高效,非选择性的,具有口服活性的二肽基肽酶 IV (DPP-IV) 抑制剂,Ki 值为 0.18 nM。
    Talabostat isomer mesylate
  • HY-U00346
    DPP-IV-IN-1 Inhibitor 99.29%
    DPP-IV-IN-1 是一种有效的 dipeptidyl peptidase IV (DPP-IV) 抑制剂,IC50 值为 4.6 nM;DPP-IV 为一种特异性的丝氨酸蛋白酶 (serine protease)。
    DPP-IV-IN-1
  • HY-117985B
    Evogliptin tartrate Inhibitor 99.71%
    Evogliptin (DA-1229) tartrat 是一种口服有效的 DPP4 抑制剂,在小鼠模型中具有显著而持久的降糖效果。Evogliptin tartrat 还可通过诱导自噬来抑制肝细胞的炎症和纤维化信号的产生。Evogliptin tartrat 可用于 2 型糖尿病、骨质疏松症,肾功能损害以及慢性肝脏炎症的研究。
    Evogliptin tartrate
  • HY-10287
    Gosogliptin Inhibitor 99.27%
    Gosogliptin 是一种有效的选择性二肽基肽酶IV (DPP-IV) 抑制剂。
    Gosogliptin
  • HY-10286
    Dutogliptin

    杜拓格利普汀

    Inhibitor 99.32%
    Dutogliptin (PHX-1149 free base) 是一种口服有效的选择性二肽基肽酶-4 (DPP4) 抑制剂,可用于 2 型糖尿病的研究。
    Dutogliptin
  • HY-16448
    Saxagliptin hydrochloride

    盐酸沙格列汀; 盐酸沙克列汀

    Inhibitor 99.71%
    Saxagliptin hydrochloride (BMS-477118 hydrochloride) 是一种有效,选择性,可逆,竞争性和具有口服活性的二肽基肽酶 4 (DPP-4) (Ki = 0.6-1.3 nM) 抑制剂。Saxagliptin hydrochloride 可用于 2 型糖尿病的研究。
    Saxagliptin hydrochloride
  • HY-112668A
    Retagliptin

    瑞格列汀

    Inhibitor 98.30%
    Retagliptin (SP2086) 是一种选择性的竞争性,且具有口服活性的二肽基肽酶 4 (DPP-4) 抑制剂。Retagliptin 可用于 2 型糖尿病 (T2DM) 的研究。
    Retagliptin
  • HY-N7653
    Azaleatin

    杜鹃黄素

    Inhibitor 98.80%
    Azaleatin 是一种从 Rhododendron 种中分离得到的 O-甲基化黄酮醇。Azaleatin 是二肽基肽酶-IV 的抑制剂。Azaleatin 可用于 2 型糖尿病和肥胖症的研究。
    Azaleatin
  • HY-147257
    Cofrogliptin Inhibitor 99.07%
    Cofrogliptin (HSK7653) (compound 2),一种四氢吡喃衍生物,是一种有效的口服 DPP-4 抑制剂,具有长效降糖作用。Cofrogliptin (compound 2) 在2型糖尿病 (T2DM) 应用中具有很大的潜力。
    Cofrogliptin
目录号 产品名 / 同用名 种属 表达系统

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.